Device / Technology News

RSS

SiMoA technology measures individual PSA molecules in prostate cancer patients: Nature Biotechnology

Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.

24 May 2010

Abviva receives new patent grant notifications for MSA technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, today provided further details about worldwide patent protection for its breast cancer risk assessment technology.

24 May 2010

New MALDI molecular imaging system offers spatial analysis of target metabolites

At the 58th ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announces a novel MALDI molecular imaging system based on the extreme performance of the solariX FTMS.

24 May 2010

New electronic device regulates nerve cell activity

A major step toward being able to regulate nerve cells externally with the help of electronics has been taken by researchers at Linköping University and the Karolinska Institute in Sweden.

24 May 2010

Pharmacist-led HBPM program improves blood pressure control

A pharmacist-led home blood pressure monitoring program supported by the American Heart Association's Heart 360 website dramatically improved blood pressure control for patients with uncontrolled hypertension, according to a study.

21 May 2010

Axis Three announces availability of new XS-400 scanner for face, breast and body procedures

Axis Three, the leader and pioneer of 3D surgical simulation tools for aesthetic consultations, today announced the availability of its new XS-400 scanner, a turnkey system designed to address face, breast, and body procedures. The only 4-position 3D scanner on the market, the elegant XS-400 captures anatomically-accurate, 3D images of a patient's face or body, and serves as a vehicle to extend Axis Three's unrivaled simulation platform to an even broader range of cosmetic procedures.

21 May 2010

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Competitive Technologies, Inc. today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment.

21 May 2010

Oberthur Technologies, SMART Association to offer smart card-centric ID solution to hospitals in North America

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of smart credentials to the U.S. Federal government, has teamed up with one of healthcare's leading smart card software providers, SMART Association Inc., to offer a powerful, proven and secure, physical and logical access smart card-based admissions solution to hospitals and clinics throughout North America.

21 May 2010

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has received additional supply of molybdenum-99 (Mo-99) to produce vital medical isotopes for its TechneLite® (Technetium Tc99m Generator) generators as the result of a recent agreement between the Institute for Radioelements (IRE), Fleurus, Belgium, and the Nuclear Research Institute (NRI), Rez, Czech Republic.

21 May 2010

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.

21 May 2010

New England Peptide launches NEPTune line of custom proteomics reagents

New England Peptide (NEP) today introduced NEPTune TM, a new proprietary line of custom proteomics reagents to help its customers to quickly and inexpensively maximize biomarker assay development and produce consistent results.

21 May 2010

Data on serum DNA blood tests for early detection of cancer to be presented at ASCO 2010

Chronix Biomedical today reported a summary of data supporting the utility of its serum DNA blood tests for the early and accurate detection of breast cancer and prostate cancer. The unique testing algorithms developed by Chronix detected and correctly identified DNA fragments in the blood from dying (apoptotic) cancer cells with 92% sensitivity and 100% specificity in both prostate cancer and breast cancer.

21 May 2010

Patients with VAD implants develop varying severities of AVWS

The findings of a 12 patient study recently published in Thrombosis and Haemostasis by University Medical Center Freiburg documented that patients implanted with a ventricular assist device (VAD) experienced a rapid onset of acquired von Willebrand syndrome (AVWS), while patients implanted with the SynCardia temporary Total Artificial Heart did not.

21 May 2010

New drug testing technique is safe and effective

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time.

21 May 2010

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.

21 May 2010

Leading cardiologist uses new imaging system

LightLab Imaging, Inc. announced today that Good Morning America featured Dr. Marco Costa, a leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University Hospitals, Case Western Reserve University, using the newest imaging technology available to hospitals in the United States – Optical Coherence Tomography.

21 May 2010

Datasource Mobility to illustrate new healthcare product from Panasonic

DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic®, the world leader in rugged mobile computers.

From PHC Europe B.V. 21 May 2010

Research team investigates infants with suspected GERD using combined pH/MII monitoring

Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.

21 May 2010

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimization required.

21 May 2010

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.

21 May 2010

Device / Technology News

SiMoA technology measures individual PSA molecules in prostate cancer patients: Nature Biotechnology

Abviva receives new patent grant notifications for MSA technology

New MALDI molecular imaging system offers spatial analysis of target metabolites

New electronic device regulates nerve cell activity

Pharmacist-led HBPM program improves blood pressure control

Axis Three announces availability of new XS-400 scanner for face, breast and body procedures

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Oberthur Technologies, SMART Association to offer smart card-centric ID solution to hospitals in North America

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

New England Peptide launches NEPTune line of custom proteomics reagents

Data on serum DNA blood tests for early detection of cancer to be presented at ASCO 2010

Patients with VAD implants develop varying severities of AVWS

New drug testing technique is safe and effective

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Leading cardiologist uses new imaging system

Datasource Mobility to illustrate new healthcare product from Panasonic

Research team investigates infants with suspected GERD using combined pH/MII monitoring

Results of BioSante's 2A/Furin technology in industrial antibody CHO expression system announced

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News